Skip to main content
Sign In
 

Neonatology - Research Funding


 

(listed alphabetically by Principal Investigator or by Section faculty member involved)

Early Placental Development in IUGR Pregnancies+
Principal Investigator: Russell V. Anthony, PhD
Co-Principal Investigator: Randall B. Wilkening, MD
Source: NICHD, NIH - HD043089-03
Amount: $1,186,999
Term: 2005 - 2009

Fetal Velocity and Amino Acid Transport in Pregnancy+
Principal Investigator: Frederick C. Battaglia, MD
Source: NIH - 5 R01 HD034837
Amount: $1,151,703
Term: 2003 - 2008

Fetal Velocity in Amino Acid Transport in Pregnancy Minority Supplement+
Principal Investigator: Frederick C. Battaglia, MD
Source: NIH -1 R01 HD034837-08 S1
Amount: $112,151/yr
Term: 2006 - 2008

Nutrient Regulation of Skeletal Muscle Signal Transduction in an Ovine Model of IUGR+
Principal Investigator: Laura D. Brown, MD
Source: TCH Research Institute
Amount: $70,000/yr
Term: 2006 - 2008

Nutrient Regulation of Skeletal Muscle Signal Transduction in an Ovine Model of IUGR (Colorado Clinical Nutrition Research Unit Pilot Project)+
Principal Investigator: Laura D. Brown, MD
Source: NIDDK, NIH - 5 P30 DK048520
Amount: $12,000/yr
Term: 2006 - 2008

Colorado Clinical Nutrition Research Unit: Metabolic Core+
Principal Investigator: Jacob E. Friedman, PhD
Source: NIDDK, NIH - 5 P30 DK048520
Amount: $171,756/yr
Term: 2005 - 2010

Mechanisms for Fetal Hepatic Programming in the Non-Human Primate+
Principal Investigator: Jacob E. Friedman, PhD
Source: NIDDK, NIH - 5 R01 DK078590
Amount: $354,426/yr
Term: 2007 - 2011

Mechanisms for Fetal Hepatic Programming in the Non-Human Primate+
Mentor: Jacob E. Friedman, PhD
Source: American Diabetes Association - PN200801-095
Amount: $45,000/yr
Term: 2008 - 2012

Mechanisms of Insulin Resistance in Human Gestational Diabetes+
Principal Investigator: Jacob E. Friedman, PhD
Source: NIDDK, NIH - 5 R01 DK062155
Amount: $1,342,838
Term: 2003 - 2007

Mechanisms of Reduced Pancreatic Beta Cell Mass and Insulin Secretion in Intrauterine Growth-Restricted Fetuses and Therapeutic Correction by Glucose and Amino Acids+
Mentor: Jacob E. Friedman, PhD
Source: TCH Research Institute
Amount: $75,000/yr
Term: 2006 - 2008

Regulation of Glucose Homeostasis by CCAAT/Enhancer Binding Protein+
Principal Investigator: Jacob E. Friedman, PhD
Source: NIDDK, NIH - 5 R01 DK059767
Amount: $293,524/yr
Term: 2007 - 2011

Role of Amino Acids in Regulation of Protein Synthesis During Intrauterine Growth Restriction+
Mentor: Jacob E. Friedman, PhD
Source: TCH Research Institute
Amount: $75,000/yr
Term: 2006 - 2008

Building Interdisciplinary Research Careers in Women’s Health
Principal Investigator: Judith G. Regensteiner, PhD
Co-Investigator: Richard D. Krugman, MD
Source: NHLBI, NIH - 5 K12 HD057022
Amount: $499,249/yr
Term: 2007 - 2012

  • Regulation of mTOR Signaling in Fetal Skeletal Muscle Metabolism: Building Interdisciplinary Research Careers in Women’s Health
    Principal Investigator: Judith G. Regensteiner, PhD
    Co-Investigator: Richard D. Krugman, MD
    Scholar: Laura D. Brown, MD
    Mentor: Jacob E. Friedman, PhD
    Source: NHLBI, NIH - 5 K12 HD057022
    Amount: $101,831/yr
    Term: 2008 - 2010

  • Fetal Programming of Skeletal Muscle Metabolism: Building Interdisciplinary Careers in Women’s Health Research
    Principal Investigator: Judith G. Regensteiner, PhD
    Co-Investigator: Richard D. Krugman, MD
    Scholar: Carrie E. McCurdy, PhD
    Mentor: Jacob E. Friedman, PhD
    Source: NHLBI, NIH - 5 K12 HD057022
    Amount: $82,456/yr
    Term: 2008 - 2010

Mechanisms for Fetal Programming by Saturated Fatty Acids in the Fat-1 Mouse (Colorado Clinical and Translational Sciences Institute)+
Principal Investigator: Margaret Heerwagen, PhD student
Mentor: Jacob E. Friedman, PhD
Source: CCTSI, NIH - T32
Amount: $28,000/yr
Term: 2008 - 2009

Molecular Biomarkers of Impaired Glucose Tolerance in Women with Gestational Diabetes
Principal Investigator: Karen Jonscher, PhD
Mentor: Jacob E. Friedman, PhD
Source: UCD NIH Center for Women’s Health Investigators Network Pilot Study
Amount: $15,000/yr
Term: 2007 - 2008

Placental Growth Hormone and Insulin Resistance in Gestational Diabetes
Principal Investigator: Lynn Barbour, MD
Mentor: Jacob E. Friedman, PhD
Source: NIDDK, NIH - K23 RR17496
Amount: $75,000/yr
Term: 2002 - 2007

Regulation of Insulin Sensitivity by p85alpha PI3-Kinase+
Principal Investigator: Carrie E. McCurdy, PhD
Mentor: Jacob E. Friedman, PhD
Source: NIDDK, NIH - 5 F32 DK075252
Amount: $50,428/yr
Term: 2006 - 2008

Regulation of Maternal Fuel Supply and Neonatal Adiposity
Principal Investigator: Lynn Barbour, MD
Co-Principal Investigator: Jacob E. Friedman, PhD
Source: NIDDK, NIH - R56 DK077630
Amount: $130,000/yr
Term: 2007 - 2009

Role of Sirtuins in Diet-Induced Hepatic Steatosis, a Proteomic Approach
Principal Investigator: Karen Jonscher, PhD
Mentor: Jacob E. Friedman, PhD
Source: UCD NIH Center for Human Nutrition Pilot Grant
Amount: $40,000
Term: 2007 - 2009

Impaired Angiogenesis in Pulmonary Hypertension+**
Principal Investigator: Jason Gien, MD
Source: TCH Research Institute
Amount: $69,290
Term: 2008

Role of Vascular Endothelial Growth Factor in Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: NHLBI, NIH - 5 K08 HL072916
Amount: $130,680/yr
Term: 2004 - 2009

Role of Vascular Endothelial Growth Factor in Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: Pulmonary Hypertension Association - PN200305-120
Amount: $312,500
Term: 2004 - 2009

VEGF Treatment for the Prevention of Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: AHA, National Center Research Program - AHA 0430179N
Amount: $65,000/yr
Term: 2004 - 2006

Fetal Glucose and Amino Acid Deprivation+
Principal Investigator: William W. Hay, Jr., MD
Co-Investigators: Marianne S. Anderson, MD, Jacob E. Friedman, PhD, and Timothy R. H. Regnault, PhD
Consultant: Paul V. Fennessey, PhD
Source: NIDDK, NIH - 5 R01 DK052138
Amount: $387,008/yr
Term: 1997 - 2007

Fetal Pancreatic Development and Insulin Secretion+
Principal Investigator: William W. Hay, Jr., MD
Source: NICHD, NIH - 5 R01 HD042815
Amount: $2,665,671
Term: 2002 - 2008

Regulation of Placental Metabolism by Glucose Supply+
Principal Investigator: William W. Hay, Jr., MD
Source: NICHD, NIH- 5 R01 HD28794
Amount: $467,311/yr
Term: 1992-2008

Training in Perinatal Medicine+
Principal Investigator: William W. Hay, Jr., MD
Source: NICHD, NIH - 5 T32 HD007186-28
Amount: $257,749/yr
Term: 1979 - 2010

Colorado Clinical and Translational Sciences Institute
Principal Investigator: Ronald J. Sokol, MD
Co-Directors: William W. Hay, Jr., MD, Michael G. Kahn, MD, PhD, Robert H. Eckel, MD, Mark W. Geraci, MD, Marc Moss, MD, and Andrew Kramer, MD
Co-Directors of Child and Maternal Health Research: Patti J. Thureen, MD, William W. Hay, Jr., MD, and Peggy Neville, PhD
Source: NCRR, NIH - UL1RR025780, KL2RR025779, TL1RR025778
Amount: $76,155,655
Term: 2008 - 2013

Pediatric Clinical Translational Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Directors: William W. Hay, Jr., MD, and Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: NCRR, NIH - MO1 RR00069
Amount: $19,434,966
Term: 2006 - 2008

Pediatric General Clinical Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Directors: William W. Hay, Jr., MD, and Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: NCRR, NIH - MO1 RR00069
Amount: $16,884,197
Term: 2001 - 2006

Residency Review and Redesign in Pediatrics
Consultant: M. Douglas Jones, Jr., MD
Source: ABP
Amount: $70,000/yr
Term: 2005 - 2009

Inhaled Nitric Oxide in the Prevention of Chronic Lung Disease*+
Principal Investigator: John P. Kinsella, MD
Co-Investigators: Steven H. Abman, MD, and Adam A. Rosenberg, MD
Source: NHLBI, NIH - R01 HL64857
Amount: $7,080,990
Term: 2000 - 2008

Long-Term Outcomes of Nitric Oxide for Ventilated Premature Babies
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Derek Angus, MD
Source: NHLBI, NIH - R01 HL 039991-04
Amount: $122,243/yr
Term: 2002 - 2007

Pilot Trial of rhSOD in Term Newborns with PPHN*++
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Steven H. Abman, MD
Source: NHLBI, NIH - 1 R21 HL085782-01A1
Amount: $250,000/yr
Term: 2006 - 2011

Clinical Proteomics Center in Lung Diseaseºº
Principal Investigator: Frank J. Accurso, MD
Source: NHLBI, NIH - U01HL081335-01
Amount: $4,216,147
Term: 2005 - 2009

  • Core A: Administrative
    Principal Investigator: Frank J. Accurso, MD
    Amount: $453,886
  • Core B: Clinical
    Principal Investigator: Steven H. Abman, MD
    Co-Investigators: John P. Kinsella, MD, and D. Dunbar Ivy, MD
    Amount: $862,397
  • Core C: Data Management
    Principal Investigator: Gary O. Zerbe, PhD
    Amount: $884,826
  • Core D: Laboratory
    Principal Investigator: Mark W. Duncan, PhD
    Amount: $1,251,968
  • Core E: Educational
    Principal Investigator: Laurie A. Shroyer, PhD
    Co-Investigator: Robin R. Deterding, MD
    Amount: $604,993

SCCOR Grant: Lung Vascular Disease in Infants and Children: Mechanisms and Treatment***
Principal Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - P50 HL084923
Amount: $12,345,967
Term: 2006 - 2011

  • Project 1: Noninvasive Inhaled NO in Premature Newborns
    Principal Investigator: John P. Kinsella, MD
    Co-Investigator: Steven H. Abman, MD
    Amount: $2,457,532
  • Project 3: Advanced Imaging and Diagnostics for Pediatric Pulmonary Hypertension
    Principal Investigators: Robin Shandas, PhD, and D. Dunbar Ivy, MD
    Amount: $2,271,467
  • Project 4: Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling
    Principal Investigator: Kurt R. Stenmark, MD
    Co-Investigators: Maria Frid, PhD, and Eva N. Grayck, MD
    Amount: $2,038,122
  • Project 5: Hypoxia-Inducible Factors in Neonatal Pulmonary Hypertension
    Principal Investigator: Carl W. White, MD
    Co-Investigators: Aftab Ahmad, PhD, Steven H. Abman, MD, and Theresa R. Grover, MD
    Amount: $2,686,424
  • Core A: Administrative Core
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $531,250
  • Core B: Noninvasive Inhaled Nitric Oxide in Premature Newborns
    Principal Investigator: Ling-Yi Chang, MD
    Co-Investigator: Steven H. Abman, MD
    Amount: $795,448
  • Core C: Clinical Research Skills Development Core
    Principal Investigator: Steven H. Abman, MD
    Amount: $531,222

SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulationº
Principal Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - P50 HL 57144
Amount: $6,415,929
Term: 2001 - 2006

  • Project I: G-Proteins in Hypoxic Pulmonary Vascular Remodeling
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $2,076,662
  • Project II: Inhaled NO and the Prevention of BPD
    Principal Investigator: Steven H. Abman, MD
    Co-Investigator: John P. Kinsella, MD
    Amount: $1,860,606
  • Project III: Prx Homeobox Genes in Pulmonary Vascular Homeostasis
    Principal Investigator: Peter L. Jones, PhD
    Amount: $1,456,087
  • Clinical Core
    Principal Investigator: John P. Kinsella, MD
    Co-Investigator: Steven H. Abman, MD
    Amount: $481,196
  • Administrative Core
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $543,369

Regulation of Insulin Sensitivity by p85alpha PI3-Kinase
Principal Investigator: Carrie E. McCurdy, PhD
Mentor: Jacob E. Friedman, PhD
Source: NIDDK, NIH - 5 F32 DK075252
Amount: $50,428/yr
Term: 2006 - 2008

Development of a Global Curriculum in Neonatal Resuscitation
Project Leader: Susan Niermeyer, MD
Source: Laerdal Foundation for Acute Medicine
Amount: $200,000/yr
Term: 2008 - 2009

Development of a Global Curriculum in Neonatal Resuscitation
Project Leader: Susan Niermeyer, MD
Source: Latter Day Saints Foundation
Amount: $160,000/yr
Term: 2008 - 2009

Regulation of Obesity-Induced Inflammation and Insulin Resistance by C/EBPbeta
Principal Investigator: Mizanoor Rahman, PhD
Source: NIDDK, NIH, DERC Pilot Award - 5 R01 DK057516
Amount: $50,000/yr
Term: 2008 - 2009

A Randomized, Masked, Placebo-Controlled Study to Assess the Safety and Efficacy of Darbepoietin Alfa Administered to Preterm Infants
Principal Investigator: Robin K. Ohls, MD
Co-Investigator: Adam A. Rosenberg, MD
Source: Thrasher Research Foundation
Amount: $45,000/yr
Term: 2006 - 2009

Mechanisms of Reduced Pancreatic Beta Cell Mass and Insulin Secretion in Intrauterine Growth-Restricted Fetuses and Therapeutic Correction by Glucose and Amino Acids+
Principal Investigator: Paul J. Rozance, MD
Mentor: Jacob E. Friedman, PhD
Source: American Diabetes Association
Amount: $138,000/yr
Term: 2008 - 2012

Mechanisms of Reduced Pancreatic Beta Cell Mass and Insulin Secretion in Intrauterine Growth-Restricted Fetuses and Therapeutic Correction by Glucose and Amino Acids+
Principal Investigator: Paul J. Rozance, MD
Source: TCH Research Institute
Amount: $70,000/yr
Term: 2007 - 2009

Reduced Beta Cell Mass in IUGR and Correction by Insulin
Principal Investigator: Paul J. Rozance, MD
Source: Pediatric Loan Repayment Grant, NIH - 2 L40 CA117814
Amount: $29,866
Term: 2008 - 2010

PROPHET Study (Prophylaxis of Early Adrenal Insufficiency to Prevent Chronic Lung Disease in the Tiny Baby)
Principal Investigator: Kristi Watterberg, MD
Co-Investigators: Elizabeth H. Thilo, MD, and Susan F. Townsend, MD
Source: NIH - RO1 HD38540 01A2
Amount: $230,000
Term: 2001 - 2006

Regulation of Hepatic Glucose Output in IUGR+
Principal Investigator: Stephanie R. Thorn, PhD
Mentor: Jacob E. Friedman, PhD
Source: NIDDK, NIH - F32 DK082207
Amount: $38,000/yr
Term: 2008 - 2010

Maximal Substrate Utilization Rates in Preterm Neonates
Principal Investigator: Patti J. Thureen, MD
Source: NCRR, NIH - 5 K24 RR018358
Amount: $715,918
Term: 2004 - 2009

Maximizing Protein Growth in the Early Neonatal Period
Principal Investigator: Patti J. Thureen, MD
Source: NICHD, NIH - 5 R01 HD046752
Amount: $302,992/yr
Term: 2005 - 2010

Fetoplacental Amino Acid Metabolism in IUG
Principal Investigator: Randall B. Wilkening, MD
Co-Principal Investigator: Timothy R. H. Regnault, PhD
Source: NICHD, NIH - 5 R01 HD041505
Amount: $1,917,480
Term: 2002 - 2008


+ Supporting research funding in the Perinatal Research Center
++ Supporting research funding in Pulmonology
* Supporting research funding in the Pediatric Heart Lung Center
** Supporting research funding in Critical Care Medicine and Pulmonology
*** Supporting research funding in Critical Care Medicine, Pulmonology, the Pediatric Heart Lung Center, the Perinatal Research Center, Cardiology, and the Center for Bioengineering
º Supporting research funding in Critical Care Medicine, Pulmonology, the Pediatric Heart Lung Center and the Perinatal Research Center
ºº Supporting research funding in Cardiology, the Pediatric Heart Lung Center and Pulmonology

Effects of Plasma Glucose and Insulin Concentrations on Glucose Transporters and Glucose/Insulin Metabolism in the Fetus
Principal Investigator: Marianne S. Anderson, MD
Source: National Institutes of Health - T32 HD07186
Amount: $170,236/yr
Term: 2000-2005

Glycemic Regulation of Fetal Glucose Metabolism
Principal Investigator: Marianne S. Anderson, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases -1 K08 DK065079
Amount: $605,000
Term: 2003-2008

Early Placental Development in IUGR Pregnancies
Principal Investigator: Russell Anthony, MD
Source: National Institutes of Health -1 R01 HD043089
Amount: $308,000/yr
Term: 2005-2009

Fetal Velocity and Amino Acid Transport in Pregnancy
Principal Investigator: Frederick C. Battaglia, MD
Source: National Institutes of Health -1 R01 HD034837
Amount: $225,000/yr
Term: 2003-2008

Fetal Velocity in Amino Acid Transport in Pregnancy Minority Supplement
Principal Investigator: Frederick C. Battaglia, MD
Source: National Institutes of Health -1 R01 HD034837-08 S1
Amount: $75,000/yr
Term: 2006-2008

Mechanisms of Insulin Resistance in GDM
Principal Investigator: Jacob E. Friedman, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO1 DK062155
Amount: $338,800
Term: 2003-2008

Role of TNFa in Gestational Diabetes Mellitus
Principal Investigator: Jacob E. Friedman, PhD
Source: American Diabetes Association
Amount: $137,802
Term: 2003-2005

Colorado Nutrition Research Unit (CNRU) Metabolic Core
Principal Investigator: Jacob E. Friedman, PhD
Source: National Institute of Health- 2 P30 DK048520
Amount: $660,000
Term: 2005-2010

Regulation of Glucose Homeostasis by C/EBPß
Principal Investigator: Jacob E. Friedman, PhD
Source: National Institutes of Health - R01-DK59767
Amount: $711,435
Term: 2000-2006

Role of VEGF in Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: Pulmonary Hypertension Association - 5 K08 HL072916
Amount: $312,500
Term: 2004-2009

VEGF Treatment for the Prevention of Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: American Heart Association, National Center Research Program - PN200305-120
Amount: $62,500/yr
Term: 2004-2006

Fetal Glucose and Amino Acid Deprivation+
Principal Investigator: William W. Hay, Jr., MD
Co-Investigators: Marianne S. Anderson, MD, Jacob E. Friedman, PhD, and Timothy R. H. Regnault, PhD
Consultant: Paul V. Fennessey, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO1 DK52138
Amount: $302,088/yr
Term: 1997-2007

Regulation of Placental Metabolism by Glucose Supply+
Principal Investigator: William W. Hay, Jr., MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - RO1HD028794
Amount: $478,557/yr
Term: 2001-2007

Fetal Pancreatic Development and Insulin Secretion+
Principal Investigator: William W. Hay, Jr., MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - RO1 HD42815
Amount: $2,129,656
Term: 2001-2007

Training in Perinatal Medicine+
Principal Investigator: William W. Hay, Jr., MD
Source: National Institutes of Health - T32 HD07186
Amount: $1,071,660
Term: 2005-2010

Inhaled Nitric Oxide in the Prevention of Chronic Lung Disease*+
Principal Investigator: John P. Kinsella, MD
Co-Investigators: Steven H. Abman, MD, and Adam A. Rosenberg, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - R01 HL64857
Amount: $7,080,990
Term: 2000-2006

Long-Term Outcomes of NO for Ventilated Premature Babies
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Derek Angus, MD
Source: National Institutes of Health, National Heart, Blood and Lung Institute
Amount: $122,243
Term: 2002-2007

Aberrant Ovine Pancreatic Development in IUGR Fetuses
Principal Investigator: Sean W. Limesand, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Amount: $400,468
Term: 2004-2005

Regulation of Insulin Sensitivity by p85alpha pI3-Kinase
Principal Investigator: Carrie E. McCurdy, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases- F 32 DK075252
Amount: $400,468
Term: 2004-2005

Low Birth Weight in Colorado: The Interaction of Smoking and Altitude
Principal Investigator: Susan Niermeyer, MD
Source: Colorado Tobacco Research Program
Amount: $153,160
Term: 2003-2005

The Effects of Estrogen on Perinatal Pulmonary Blood Flow*+
Principal Investigator: Thomas A. Parker, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - 1 K08 HL04206
Amount: $590,750
Term: 2000-2005

Early Placental Development in IUGR Pregnancies+
Co-Principal Investigators: Timothy R. H. Regnault, PhD, and Russell V. Anthony, PhD
Source: National Institutes of Health
Amount: $1,000,000
Term: 2003-2008

Low Birth Weight Clinical Trial
Principal Investigator: Adam A. Rosenberg, MD
Source: Private Funding
Amount: $44,298
Term: 2003-2005

SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulationº
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - P50 HL 57144
Amount: $6,415,929
Term: 2001-2006

  • Project I: G-Proteins in Hypoxic Pulmonary Vascular Remodeling
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $2,076,662
  • Project II: Inhaled NO and the Prevention of BPD
    Principal Investigator: Steven H. Abman, MD
    Co-Investigator: John P. Kinsella, MD
    Amount: $1,860,606
  • Project III: Prx Homeobox Genes in Pulmonary Vascular Homeostasis
    Principal Investigator: Peter L. Jones, PhD
    Amount: $1,456,087
  • Clinical Core
    Principal Investigator: John P. Kinsella, MD
    Co-Investigator: Steven H. Abman, MD
    Amount: $481,196
  • Administrative Core
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $543,369

PROPHET Study (Prophylaxis of Early Adrenal Insufficiency to Prevent Chronic Lung Disease in the Tiny Baby)
Principal Investigator: Kristi Watterberg, MD
Co-Investigators: Elizabeth H. Thilo, MD, and Susan F. Townsend, MD
Source: National Institutes of Health - RO1 HD38540 01A2
Amount: $230,000
Term: 2001-2006

Maximal Substrate Utilization Rates in Preterm Neonates
Principal Investigator: Patti J. Thureen, MD
Source: National Institutes of Health National Center For Research Resources- 5 K24 RR018358
Amount: $143,748/yr
Term: 2004-2009

Maximizing Protein Growth in the Early Neonatal Period
Principal Investigator: Patti J. Thureen, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - 1 R01 HD046752
Amount: $319,550/yr
Term: 2005-2010

Fetoplacental Amino Acid Metabolism in IUGR+
Principal Investigator: Randall B. Wilkening, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - RO1 HD 41505-01
Amount: $285,150
Term: 2002-2007


+ Supporting research funding in the Perinatal Research Center
++ Supporting research funding in Pulmonology
* Supporting research funding in the Pediatric Heart Lung Center
** Supporting research funding in Critical Care Medicine and Pulmonology
*** Supporting research funding in Critical Care Medicine, Pulmonology, the Pediatric Heart Lung Center, the Perinatal Research Center, Cardiology, and the Center for Bioengineering
º Supporting research funding in Critical Care Medicine, Pulmonology, the Pediatric Heart Lung Center and the Perinatal Research Center
ºº Supporting research funding in Cardiology, the Pediatric Heart Lung Center and Pulmonology

Glycemic Regulation of Fetal Glucose Metabolism
Principal Investigator: Marianne S. Anderson, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases -1 K08 DK065079-01
Amount: $605,000
Term: 2003-2008

Effects of Plasma Glucose and Insulin Concentrations on Glucose Transporters and Glucose/Insulin Metabolism in the Fetus
Principal Investigator: Marianne S. Anderson, MD
Source: National Institutes of Health - T32 HD07186
Amount: $170,236/yr
Term: 2000-2005

Placental-Fetal Hormonal Interactions
Principal Investigator: Russell V. Anthony, PhD
Source: CSU College of Veterinary Medicine and Biomedical Sciences
Amount: $87,000
Term: 2000-2003

Colorado WRHR Career Development Center
Principal Investigator: Ronald S. Gibbs, MD
Scientific Directors: Russell V. Anthony, PhD, and William W. Hay, Jr., MD
Source: National Institutes of Health - K12HD01271
Amount: $365,788/yr
Term: 1999-2004

Linking Clinical Severity and Functional Correlates with Longitudinal Studies and Intervention
Principal Investigator: Frederick C. Battaglia, MD
Source: March of Dimes Birth Defects Foundation
Amount: $242,766
Term: 2000-2003

Regulation of Glucose Homeostasis by C/EBPß
Principal Investigator: Jacob E. Friedman, PhD
Source: National Institutes of Health - R01-DK59767
Amount: $700,000
Term: 2000-2004

Mechanisms and Effects of Decreased Glucose Insulin Sensitivity in Pregnant Women
Principal Investigator: Patrick Catalano, MD
Co-Investigator: Jacob E. Friedman, PhD
Source: National Institutes of Health
Amount: $437,000
Term: 1998-2003

Mechanisms of Insulin Resistance in GDM
Principal Investigator: Jacob E. Friedman, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO1 DK062155
Amount: $351,250
Term: 2003-2008

Colorado Clinical Nutrition Research Unit
Principal Investigator: James O. Hill, PhD
Principal Investigator, Molecular Biology Core: Jacob E. Friedman, PhD
Source: National Institutes of Health - DK48520
Amount: $555,164
Term: 2002-2005

Role of TNFa in Gestational Diabetes Mellitus
Principal Investigator: Jacob E. Friedman, PhD
Source: American Diabetes Association
Amount: $157,512
Term: 2003-2005

Role of Vascular Endothelial Growth Factor in Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: National Institutes of Health Mentored Clinical Scientist Development Award - K08 HL072916
Amount: $130,680/yr
Term: 2004-2009

Role of Vascular Endothelial Growth Factor in Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: Pulmonary Hypertension Association
Amount: $62,500/yr
Term: 2004-2009

Vascular Endothelial Growth Factor (VEGF) Treatment for the Prevention of Neonatal Pulmonary Hypertension*+
Principal Investigator: Theresa R. Grover, MD
Source: American Heart Association - National Center Research Program
Amount: $260,000 (only utilized for the first quarter of 2004)
Term: 2004-2007

Fetal Pancreatic Development and Insulin Secretion+
Principal Investigator: William W. Hay, Jr., MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - RO1 HD42815
Amount: $2,129,656
Term: 2001-2006

Training in Perinatal Medicine+
Principal Investigator: William W. Hay, Jr., MD
Source: National Institutes of Health - T32 HD07186
Amount: $800,000
Term: 2000-2005

Fetal Glucose and Amino Acid Deprivation+
Principal Investigator: William W. Hay, Jr., MD
Co-Investigators: Marianne S. Anderson, MD, Jacob E. Friedman, PhD, and Timothy R. H. Regnault, PhD
Consultant: Paul V. Fennessey, PhD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO1 DK52138
Amount: $302,088/yr
Term: 1997-2007

Spiral Electrode Sensor for Intrapartum Fetal Oximetry
Consultant: William W. Hay, Jr., MD
Source: National Institutes of Health - R43-HD045074
Amount: $87,910
Term: 2003-2004

Inhaled Nitric Oxide in the Prevention of Chronic Lung Disease*+
Principal Investigator: John P. Kinsella, MD
Co-Investigators: Steven H. Abman, MD, and Adam A. Rosenberg, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - R01 HL64857-01A1
Amount: $7,080,990
Term: 2000-2004

Long-Term Outcomes of Nitric Oxide for Ventilated Premature Babies
Principal Investigator: Derek Angus, MD
Co-Principal Investigator: John P. Kinsella, MD
Source: National Institutes of Health - National Heart, Blood and Lung Institute - R01 HL039991
Amount: $122,243
Term: 2002-2007

Aberrant Ovine Pancreatic Development in IUGR Fetuses
Principal Investigator: Sean W. Limesand, PhD
Source: National Institutes of Health - National Institute of Diabetes and Digestive and Kidney Diseases - K01 DK067393
Amount: $400,468
Term: 2004-2005

Low Birth Weight in Colorado: The Interaction of Smoking and Altitude
Principal Investigator: Susan Niermeyer, MD
Source: Colorado Tobacco Research Program
Amount: $153,160
Term: 2003-2005

The Effects of Estrogen on Perinatal Pulmonary Blood Flow*+
Principal Investigator: Thomas A. Parker, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - 1 K08 HL04206-01
Amount: $590,750
Term: 2000-2005

Early Placental Development in IUGR Pregnancies+
Co-Principal Investigators: Timothy R. H. Regnault, PhD, and Russell V. Anthony, PhD
Source: National Institutes of Health
Amount: $1,000,000
Term: 2003-2008

Low Birth Weight Clinical Trial
Principal Investigator: Adam A. Rosenberg, MD
Source: Private Funding
Amount: $44,298
Term: 2003-2005

SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulationº
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - P50 HL 57144
Amount: $6,415,929
Term: 2001-2006

  • Project I: G-Proteins in Hypoxic Pulmonary Vascular Remodeling
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $2,076,662
  • Project II: Inhaled NO and the Prevention of BPD
    Principal Investigator: Steven H. Abman, MD
    Co-Investigator: John P. Kinsella, MD
    Amount: $1,860,606
  • Project III: Prx Homeobox Genes in Pulmonary Vascular Homeostasis
    Principal Investigator: Peter L. Jones, PhD
    Amount: $1,456,087
  • Clinical Core
    Principal Investigator: John P. Kinsella, MD
    Co-Investigator: Steven H. Abman, MD
    Amount: $481,196
  • Administrative Core
    Principal Investigator: Kurt R. Stenmark, MD
    Amount: $543,369

Maximal Substrate Utilization Rates in Preterm Neonates
Principal Investigator: Patti J. Thureen, MD
Source: National Institutes of Health - 1 K24 RR018358-01
Amount: $667,104
Term: 2004-2009

Nitrogen Metabolism in Growth-Restricted Neonates
Principal Investigator: Patti J. Thureen, MD
Source: March of Dimes Birth Defects Foundation - 6-FY00-126
Amount: $162,237
Term: 2000-2003

Conventional vs. High Protein Intake Rates to ELBW Neonates
Principal Investigator: Patti J. Thureen, MD
Source: National Institutes of Health - 1 R03 HD39842
Amount: $132,492/yr
Term: 2001-2003

Development of a Calorimetry Performance and Calibration Laboratory
Principal Investigator: Patti J. Thureen, MD
Source: The Children's Hospital Research Institute
Amount: $27,880
Term: 2000-2003

PROPHET Study (Prophylaxis of Early Adrenal Insufficiency to Prevent Chronic Lung Disease in the Tiny Baby)
Principal Investigator: Kristi Watterberg, MD
Co-Investigators: Elizabeth H. Thilo, MD, and Susan F. Townsend, MD
Source: National Institutes of Health - RO1 HD38540 01A2
Amount: $230,000
Term: 2001-2006

Fetoplacental Amino Acid Metabolism in IUGR
Principal Investigator: Randall B. Wilkening, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - RO1 HD 41505-01
Amount: $285,150
Term: 2002-2007


+ Supporting research funding in the Perinatal Research Center
++ Supporting research funding in Pulmonology
* Supporting research funding in the Pediatric Heart Lung Center
** Supporting research funding in Critical Care Medicine and Pulmonology
*** Supporting research funding in Critical Care Medicine, Pulmonology, the Pediatric Heart Lung Center, the Perinatal Research Center, Cardiology, and the Center for Bioengineering
º Supporting research funding in Critical Care Medicine, Pulmonology, the Pediatric Heart Lung Center and the Perinatal Research Center
ºº Supporting research funding in Cardiology, the Pediatric Heart Lung Center and Pulmonology

Head CT in the Evaluation of 1st Afebrile Seizures
Principal Investigator: Lalit Bajaj, MD, MPH
Co-Investigators: Mark G. Roback, MD, Louis C. Hampers, MD, MBA, Carol Okada, MD, and Rebecca Fastle, MD
Term: 2000-2004

Postreduction Management of Intussusception
Principal Investigator: Lalit Bajaj, MD, MPH
Co-Investigators: Mark G. Roback, MD, and Shayne Bland, MSc
Term: 2000-2002

Emergency Medical Services for Children Partnership Grant
Principal Investigator: F. Keith Battan, MD
Source: US Department of Health and Human Services, Maternal and Child Health Bureau -
FLAEMS01-00250
Amount: $122,000
Term: 2000-2001

L.O.C.O. (Latinos Overcoming Cultural Obstacles) "Needs Assessment for The Children's Hospital"
Principal Investigator: Sonja Burbano-O'Leary, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Source: Colorado Chapter of the American Academy of Pediatrics
Amount: $3,000
Term: 2001

The Truth about Language Barriers
Principal Investigator: Sonja Burbano-O'Leary, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Stephen Federico, MD
Source: Colorado Chapter of the American Academy of Pediatrics
Amount: $3,000
Term: 2001-ongoing

Jungle Mobile: A Mobile Injury Prevention Project for Children
Principal Investigator: Kathryn D. Emery, MD
Co-Investigators: Allison Hawkes, MD, MS, Theresa Rapstine, RN, and Victoria Cassenbaugh, RN
Term: 1998-ongoing

A Screening Tool for the Detection of Child Abuse in the Emergency Department Setting
Joint Project with the Child Advocacy Protection Team

Principal Investigator: Kathryn D. Emery, MD
Term: 2001

Seat Belt and Car Safety Seat Use in SUVs
Primary Investigator: Kathryn D. Emery, MD
Co-Investigators: Lisa Hardin Van Bramer, MD, and Kevin Raines, MD
Source: National Highway Traffic Safety Administration - STNH22-01-H-05-257
Amount: $350,000
Term: 2001-2003

Childhood Injury Prevention Concerns of Migrant and Seasonal Farm Workers in Weld County
Principle Investigator: Kathryn D. Emery, MD
Co-Investigator: S. Glenn Faries, MD
Source: Colorado Injury Control Research Center
Amount: $15,000
Term: 2002-2003

Domestic Violence Policies in Pediatric Emergency Departments
Principle Investigator: Kathryn D. Emery, MD
Co-Investigators: Sheila Sullivan, MD, Andrew P. Sirotnak, MD, and Stephanie Stronks-Knapp, MD
Term: 2002-ongoing

Development of an Injury-Free Coalition for Kids
Principal Investigator: S. Glenn Faries, MD
Co-Investigator: Kathryn D. Emery, MD
Term: 2001-ongoing

Resident Education in the Emergency Department
Principal Investigator: S. Glenn Faries, MD
Term: 2002-ongoing

Need for Atropine for Emergent Pediatric Intubations
Principal Investigator: Rebecca Fastle, MD
Co-Investigator: Mark G. Roback, MD
Term: 1999-ongoing

Resuscitation Teaching at Primary Care Centers
Principal Investigator: Margaret Ferguson, MD
Co-Investigator: Mark G. Roback, MD
Term: 1998-ongoing

Utility of Anaerobic Blood Cultures in a Pediatric Emergency Department
Principal Investigator: Stephen Freedman, MD
Co-Investigator: Genie E. Roosevelt, MD, MPH
Term: 2001-2003

PEM Collaborative Research Committee, Cerebral Edema and DKA
Principal Investigator: Nicole Glaser, MD
Co-Investigator: Mark G. Roback, MD
Term: 1998-2001

Comparison of Oral Prednisone vs. Dexamethasone in Pediatric Asthma
Principal Investigator: Richard A. Greenberg, MD
Co-Investigators: Genie E. Roosevelt, MD, MPH, and Gwendolyn S. Kerby, MD
Term: 2002-ongoing

Peak Flow vs. Spirometry in Acute Asthma
Principal Investigator: David Gutglass, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 1997-ongoing

A.C.C.E.S.S. for Latinos: After-Hours Call Center and Extended Spanish Service
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: Lauren Clark, PhD, RN, and Stephen Berman, MD
Term: 2001-2002

The Impact of Interpreters on Resource Utilization in a Pediatric Emergency Department
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigator: Jennifer McNulty, MD
Term: 1999-2002

Physician-Based Practice Pattern Variations in the Management of AGE
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigator: Elizabeth Powell, MD, MPH
Term: 2001-ongoing

Practice Variation in the Management of Croup
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: S. Glenn Faries, MD, and Steven R. Poole, MD
Term: 1999-2002

Regional After-Hours Urgent Care Provided by a Tertiary Children's Hospital
Principal Investigator: Louis C. Hampers, MD, MBA
Co-Investigators: S. Glenn Faries, MD, and Steven R. Poole, MD
Term: 2001-2002

Booster Seat Project
Principal Investigator: Lisa Hardin Van Bramer, MD
Co-Investigator: Kathryn D. Emery, MD
Source: Emergency Medical Services and Kiwanis Pediatric Trauma Institute
Amount: $18,000
Term: 2001-2002

Association of Influenza with Bacterial Tracheitis
Principal Investigator: Ron L. Kaplan, MD
Co-Investigators: Mark G. Roback, MD, and Peggy Kelly, MD
Term: 2002-ongoing

Safety, Tolerability and Efficacy Study of Levalbuterol and Racemic Albuterol in Pediatric Patients Birth to 48 Months Old with Reactive Airways Disease in an Acute Setting
Principal Investigator: Gwendolyn S. Kerby, MD
Co-Investigator: S. Glenn Faries, MD
Term: 2001-2002

Effect of Ondansetron on Ketamine Sedation-Associated Vomiting
Principal Investigator: William T. Langston, MD
Co-Investigators: Joseph E. Wathen, MD, and Mark G. Roback, MD
Source: The Children's Hospital Research Institute
Amount: $5,000
Term: 2002-ongoing

Effect of Medical Spanish Classes on Satisfaction of Hispanic Patients in Pediatric Emergency Department
Principal Investigator: Suzanne Mazor, MD
Co-Investigators: Vidya Chande, MD, Louis C. Hampers, MD, MBA, and Steven Krug, MD
Term: 2000-2002

Interpretation of Traumatic Lumbar Punctures: Who Can Go Home?
Principal Investigator: Suzan Mazor, MD
Co-Investigators: Jennifer McNulty, MD, and Genie E. Roosevelt, MD, MPH
Term: 2001-ongoing

How Is Emergency Department Decision-Making Affected by the Existence of Reliable Follow-Up?
Principal Investigator: Jennifer McNulty, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Steven Krug, MD
Term: 1999-2001

Decision Rules for Obtaining Radiographs in Pediatric Knee Injuries
Principal Investigator: Brian Moore, MD
Co-Investigators: Louis C. Hampers, MD, MBA, and Kathryn Emery, MD
Term: 1998-ongoing

Indications for Knee Radiographs in Pediatric Patients with Acute Knee Injuries/Validation of a Clinical Decision Rule
Principal Investigator: Brian Moore, MD
Co-Investigators: Carol Turner, MD, and Kathryn D. Emery, MD
Term: 2000-ongoing

Correlation of Hemolysis with Facticous Hyperkalemia
Principal Investigator: Heather Owens, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing

Acute Complication of Type 1 Diabetes in Children
Primary Investigator: Arleta B. Rewers, MD, PhD
Co-Investigators: Mark G. Roback, MD, and Joan P. Bothner, MD
Term: 2001-ongoing

Childhood Pedestrian Injuries
Primary Investigator: Arleta B. Rewers, MD, PhD
Term: 2002-ongoing

Femur Fractures and Associated Injuries
Principal Investigator: Arleta B. Rewers, MD, PhD
Co-Investigators: Kathryn D. Emery, MD, and F. Keith Battan, MD
Term: 2000-ongoing

Are Chest X-Rays Required for all First-Time Wheezers?
Principal Investigator: Mark G. Roback, MD
Co-Investigators: Mark E. Anderson, MD, and John D. Strain, MD
Term: 1998-ongoing

Comparison of the Efficacy and Safety of Sedation Drugs Used in a Pediatric Emergency Department
Principal Investigator: Mark G. Roback, MD
Co-Investigators: Joseph E. Wathen, MD, and Joan P. Bothner, MD
Term: 1999-ongoing

IV vs. IM Ketamine Sedation in the Pediatric Emergency Department
Principal Investigator: Mark G. Roback, MD
Co-Investigator: Joseph E. Wathen, MD
Source: The Children's Hospital Research Institute
Amount: $35,000
Term: 2000-ongoing

Pediatric Resuscitation Practice and Success Rate
Principal Investigator: Mark G. Roback, MD
Co-Investigator: Rebecca Fastle, MD
Term: 2000-ongoing

Predictors of Which Patients will Benefit from Observations vs. Hospital Admission
Principal Investigator: Genie E. Roosevelt, MD, MPH
Co-Investigator: S. Glenn Faries, MD
Term: 2002-ongoing

Randomized, Double-Blind Study of Intravenous Fluids With and Without Dextrose in the Treatment of Dehydration in Pediatric Patients with Vomiting and Ketosis
Principal Investigator: Genie E. Roosevelt, MD, MPH
Term: 2002-ongoing

The Effect of Dehydration on the QT Interval of Healthy Children
Principal Investigator: Carl Shaw, MD
Co-Investigators: Joseph E. Wathen, MD, and Michael S. Schaffer, MD
Term: 2001

The Prevalence of Urinary Tract Infections in Febrile Children with AGE
Principal Investigator: Carl Shaw, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing

Use of Complementary Medicine in Pediatric Patients with Asthma
Principal Investigator: Alison Siegel Tothy, MD
Co-Investigator: Genie E. Roosevelt, MD, MPH
Term: 2001-2002

Associations between Insurance Type and Pediatric Admission Rate in Colorado, 1993-1999: Is Managed Care Fulfilling Its Promise?
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Jill Joseph, MD, PhD, and James K. Todd, MD
Term: 2000-ongoing

Associations of Parental Depression and Child Health Outcomes
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Allison Kempe, MD, John Steiner, MD, David Price, MD, and David Magid, MD
Term: 2002-ongoing

Comparison of the Longitudinal Marginal Cost, Morbidity and Mortality of Inflicted and Unintentional Head Injuries in Young Children in a Nationwide Sample of Children's Hospitals
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Anne Libby, PhD
Term: 2001-ongoing

Costs of Childhood Physical Abuse: Comparing Inflicted and Unintentional Head Injuries in Colorado Inpatients Under Three Years Old
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Anne Libby, PhD
Term: 2001-ongoing

Epidemiology of Pediatric Psychiatric Visits to US Emergency Departments, Based on the National Hospital Ambulatory Medical Care Survey 1995-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Hospital-Level Predictors of Inefficiency Amongst Hospitalized Patients in New York State
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigators: Jill Joseph, MD, PhD, and Andrew Racine, MD, PhD
Term: 2000-ongoing

Management of Acute Gastroenteritis Visits to Emergency Departments Based on the National Hospital Ambulatory Medical Care Survey, 1995-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Management of Bronchiolitis Visits to Emergency Departments Based on the National Hospital Ambulatory Medical Care Survey, 1993-1999
Principal Investigator: Marion R. Sills, MD, MPH
Co-Investigator: Shayne Bland, MSc
Term: 2001-ongoing

Comparison of Fascia Iliaca Compartment Nerve Block to Traditional Systemic Analgesics for Femur Fractures in a Pediatric Emergency Department
Principal Investigator: Joseph E. Wathen, MD
Co-Investigators: Glen Merritt, MD, Gaia Georgopoulos, MD, and F. Keith Battan, MD
Source: The Children's Hospital Research Institute
Amount: $17,594
Term: 2001-2004

Pediatric EKG Interpretation Accuracy by Pediatric Emergency Medicine Physicians
Principal Investigator: Joseph E. Wathen, MD
Co-Investigators: Arleta Rewers, MD, PhD, Angela Yetman MD, and Michael Schaffer MD
Term: 2001-ongoing

A Randomized Trial of Telephonic vs. On-Site Language Interpretation in a Pediatric ED
Principal Investigator: Ethan S. Wiener, MD
Co-Investigator: Louis C. Hampers, MD, MBA
Term: 2002-ongoing